WallStreetZenWallStreetZen

NASDAQ: TBPH
Theravance Biopharma Inc Stock Ownership - Who owns Theravance Biopharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Theravance Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Rhonda FarnumSVP COMM MEDICAL AFFAIRS2026-05-205,678$16.55
$93.97kSell
Rick E. WinninghamCHIEF EXECUTIVE OFFICER2026-05-2020,038$16.55
$331.63kSell
Aziz SawafSVP CHIEF FINANCIAL OFFICER2026-05-208,670$16.55
$143.49kSell
Aine MillerSVP DEV HEAD OF IRE OFFICE2026-05-206,827$16.55
$112.99kSell
Brett A. GrimaudSVP GEN COUNSEL AND SECRETARY2026-05-208,829$16.55
$146.12kSell
Rhonda FarnumSVP COMM MEDICAL AFFAIRS2026-03-1615,534$14.00
$217.48kSell
Rhonda FarnumSVP COMM MEDICAL AFFAIRS2026-03-167,767$13.92
$108.09kSell
Rhonda FarnumSVP COMM MEDICAL AFFAIRS2026-03-167,766$13.92
$108.07kSell
Rick E. WinninghamCHIEF EXECUTIVE OFFICER2026-02-2074,975$19.66
$1.47MSell
Brett A. GrimaudSVP GEN COUNSEL AND SECRETARY2026-02-2020,833$19.66
$409.58kSell

1 of 4

TBPH insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TBPH insiders and whales buy or sell their stock.

TBPH Shareholders

What type of owners hold Theravance Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Eli Samaha34.96%18,022,500$294.49MInsider
Glaxosmithkline PLC18.71%9,644,807$157.60MInsider
Madison Avenue Partners LP18.45%9,511,150$155.41MInstitution
Weiss Asset Management LP14.46%7,457,060$121.85MInsider
Weiss Asset Management LP14.46%7,457,060$121.85MInstitution
Newtyn Management LLC9.39%4,841,629$79.11MInstitution
Blackrock Inc8.33%4,296,290$70.20MInstitution
Irenic Capital Management LP5.36%2,760,948$45.11MInstitution
Vanguard Capital Management LLC3.46%1,783,753$29.15MInstitution
Rick E. Winningham3.39%1,747,023$28.55MInsider

1 of 3

TBPH vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TBPH53.64%46.36%Net SellingNet Selling
EVMN62.05%37.95%Net Buying
XNCR72.60%27.40%Net SellingNet Selling
CGEM57.24%42.76%Net BuyingNet Selling
OMER42.57%5.00%Net Buying
View Top Biotech Stocks

Theravance Biopharma Stock Ownership FAQ

Who owns Theravance Biopharma?

Theravance Biopharma (NASDAQ: TBPH) is owned by 96.61% institutional shareholders, 83.49% Theravance Biopharma insiders, and 0.00% retail investors. Eli Samaha is the largest individual Theravance Biopharma shareholder, owning 18.02M shares representing 34.96% of the company. Eli Samaha's Theravance Biopharma shares are currently valued at $294.49M.

If you're new to stock investing, here's how to buy Theravance Biopharma stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.